600 e quaternary pump (Waters Corporation)
Waters Corporation manufactures this product 
86
Structured Review
Waters Corporation
600 e quaternary pump
600 E Quaternary Pump, supplied by Waters Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/600+quaternary+pump/pm38101032-88-18-24
Average 86 stars, based on 1 article reviews
600 E Quaternary Pump, supplied by Waters Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/600+quaternary+pump/pm38101032-88-18-24
Average 86 stars, based on 1 article reviews
600 e quaternary pump - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
High Performance Liquid Chromatography:Article Title: Extending and maintaining micropore viability of microneedle treated skin with lipid biosynthesis inhibitors for sustained drug delivery Article Snippet: .. The HPLC system consisted of a Waters 717 plus auto-sampler, a Article Title: HPLC-UV analytical method for determination of pizotifen after in vitro transdermal diffusion studies. Article Snippet: Pizotifen malate is an antihistamine and serotonin inhibitor used in the preventive treatment of migraine and eating disorders.. A simple, rapid, accurate and precise high-performance liquid chromatography (HPLC) method involving ultraviolet detection was validated for the quantitative analysis of pizotifen malate in samples from in vitro transdermal diffusion studies.. The method was validated for specificity, linearity, accuracy, precision, limit of detection, limit of quantification and robustness. Article Title: Development of a codrug approach for sustained drug delivery across microneedle-treated skin. Article Snippet: Microneedle (MN) enhanced transdermal drug delivery enables the transport of a host of molecules that cannot be delivered across the skin by passive diffusion alone.. However, the skin being a self-regenerating organ heals itself and thus prevents delivery of molecules through micropores for a 7-day time period, the ideal transdermal delivery goal.. Hence, it is necessary to employ a second drug molecule, a cyclooxygenase inhibitor to enhance pore lifetime by decreasing local subclinical inflammatory response following MN treatment. Article Title: Glutamic Acid Increased Methotrexate Polyglutamation and Cytotoxicity in a CCRF-SB Acute Lymphoblastic Leukemia Cell Line Article Snippet: .. HPLC analysis was performed in a Waters chromatograph (Waters, Milford, MA, USA) equipped with a Article Title: Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skin. Article Snippet: The passive delivery rate of naltrexone (NTX) through intact skin is too slow to achieve therapeutic plasma levels in humans from a reasonably sized transdermal patch.. A physical enhancement method—microneedles (MNs)—has been shown to afford a substantial increase in the percutaneous flux of NTX hydrochloride in vitro.. However, for better therapeutic effect and decrease in the transdermal patch area, further enhancement is desired. Article Title: Radiolabeling of HTE1PA: A new monopicolinate cyclam derivative for Cu-64 phenotypic imaging. In vitro and in vivo stability studies in mice. Article Snippet: ⁎ Correspondence to: R. Tripier, Université de Bret 6521, SFR ScInBioS, UFR des Sciences et Techniques, 6 93837, 29238 Brest Cedex 3, France.. Tel.. : +33 2 980161 ⁎⁎ Correspondence to: A. Faivre-Chauvet, Institut de Rec de Nantes (IRS UN), CRCNA-UMR_S 892-C 6299, 8 qua Nantes Cedex, France. Software:Article Title: Extending and maintaining micropore viability of microneedle treated skin with lipid biosynthesis inhibitors for sustained drug delivery Article Snippet: .. The HPLC system consisted of a Waters 717 plus auto-sampler, a Article Title: Development of a codrug approach for sustained drug delivery across microneedle-treated skin. Article Snippet: Microneedle (MN) enhanced transdermal drug delivery enables the transport of a host of molecules that cannot be delivered across the skin by passive diffusion alone.. However, the skin being a self-regenerating organ heals itself and thus prevents delivery of molecules through micropores for a 7-day time period, the ideal transdermal delivery goal.. Hence, it is necessary to employ a second drug molecule, a cyclooxygenase inhibitor to enhance pore lifetime by decreasing local subclinical inflammatory response following MN treatment. Article Title: Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skin. Article Snippet: The passive delivery rate of naltrexone (NTX) through intact skin is too slow to achieve therapeutic plasma levels in humans from a reasonably sized transdermal patch.. A physical enhancement method—microneedles (MNs)—has been shown to afford a substantial increase in the percutaneous flux of NTX hydrochloride in vitro.. However, for better therapeutic effect and decrease in the transdermal patch area, further enhancement is desired. Article Title: Radiolabeling of HTE1PA: A new monopicolinate cyclam derivative for Cu-64 phenotypic imaging. In vitro and in vivo stability studies in mice. Article Snippet: ⁎ Correspondence to: R. Tripier, Université de Bret 6521, SFR ScInBioS, UFR des Sciences et Techniques, 6 93837, 29238 Brest Cedex 3, France.. Tel.. : +33 2 980161 ⁎⁎ Correspondence to: A. Faivre-Chauvet, Institut de Rec de Nantes (IRS UN), CRCNA-UMR_S 892-C 6299, 8 qua Nantes Cedex, France. Modification:Article Title: Development of a codrug approach for sustained drug delivery across microneedle-treated skin. Article Snippet: Microneedle (MN) enhanced transdermal drug delivery enables the transport of a host of molecules that cannot be delivered across the skin by passive diffusion alone.. However, the skin being a self-regenerating organ heals itself and thus prevents delivery of molecules through micropores for a 7-day time period, the ideal transdermal delivery goal.. Hence, it is necessary to employ a second drug molecule, a cyclooxygenase inhibitor to enhance pore lifetime by decreasing local subclinical inflammatory response following MN treatment. Article Title: Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skin. Article Snippet: The passive delivery rate of naltrexone (NTX) through intact skin is too slow to achieve therapeutic plasma levels in humans from a reasonably sized transdermal patch.. A physical enhancement method—microneedles (MNs)—has been shown to afford a substantial increase in the percutaneous flux of NTX hydrochloride in vitro.. However, for better therapeutic effect and decrease in the transdermal patch area, further enhancement is desired. |